论文部分内容阅读
目的:探析克拉霉素联合噻托溴胺治疗慢性阻塞性肺疾病的临床效果。方法:选取2014年5月-2015年5月本院收治的78例慢性阻塞性肺疾病患者,将其随机分为对照组和观察组,每组39例。对照组给予噻托溴胺治疗,观察组给予克拉霉素联合噻托溴胺治疗,对两组患者的临床治疗效果进行对比分析。结果:观察组患者的临床治疗有效率为97.44%,对照组患者的临床治疗有效率为76.92%,差异具有统计学意义(P<0.05);经治疗后,观察组患者的肺部改善情况优于对照组,差异具有统计学意义(P<0.05)。结论:克拉霉素联合噻托溴胺治疗慢性阻塞性肺疾病的临床有效率较高,患者的肺功能改善情况较好。
Objective: To investigate the clinical effect of clarithromycin combined with tiotropium in the treatment of chronic obstructive pulmonary disease. Methods: From May 2014 to May 2015, 78 patients with chronic obstructive pulmonary disease admitted to our hospital were randomly divided into control group and observation group, with 39 cases in each group. The control group was treated with tiotropium, the observation group was treated with clarithromycin combined with tiotropium, and the clinical effects of the two groups were compared. Results: The effective rate of clinical treatment in the observation group was 97.44%, while that in the control group was 76.92%, the difference was statistically significant (P <0.05). After treatment, the lung improvement in the observation group was superior In the control group, the difference was statistically significant (P <0.05). Conclusion: Clarithromycin combined with tiotropium in the treatment of chronic obstructive pulmonary disease clinical efficiency is higher, the patient’s lung function improvement is better.